MarkWide Research


Diagnostic Ecg Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: September, 2022
No of Pages: 153
Delivery Format: PDF + Excel


The global diagnostic electrocardiograph market is expected to witness growth over the forecast period. Increasing incidences of cardiovascular diseases and lifestyle associated diseases such as ischemic heart disease (IHD), hypertensive heart disease, stroke, and peripheral artery diseases are anticipated to drive the market growth. Increasing geriatric population base, improving healthcare infrastructure, and supportive reimbursement policies are expected to drive the global diagnostic electrocardiograph (ECG) market. Furthermore, continuous advancement in technologies for ECG devices coupled with introduction of remote monitoring devices is expected to fuel the growth of the diagnostic ECG market over the forecast period. Developing nations witness high growth opportunities in comparison with developed countries owing to the fact that the market of developed nations is almost saturated. Additionally, developing nations are expected to witness lucrative growth opportunities owing to favorable government policies, increasing expenditure in healthcare, and largely untapped potential market.

Diagnostic Ecg Market  Report Scope and Segmentation

UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

The global diagnostic electrocardiograph market is studied under three main segments namely product type, lead type, and end use. On the basis of product type, the market is classified into halter monitors, resting ECG systems, and stress ECG monitors. In 2014, halters monitors was the large segment due to a remarkable increase in the number of hospitals coupled with growth in the hospital’s expenditure in ECG devices. By lead type, the market is segmented into single lead type ECG devices, 3 to 6 type ECG devices, 12 lead type ECG devices, and other lead type ECG devices. In 2014, 3 to 6 type ECG devices market was dominant in the entire ECG market and is expected to show significant growth rate owing to high-efficiency rate of these devices at low cost. On the basis end-use, the market is again divided into hospitals, clinics, ambulatories and other institutions. In 2014, the hospital market was dominating the entire ECG market owing to tremendous increase in the number of hospitals and high expenditure in buying ECG devices.

Geographically, the global diagnostic ECG market is studied under five different regions namely, North America, Asia Pacific, Latin America, Europe, and MEA. In 2014, North America was the most dominant region in terms of revenue. Owing to rising number of geriatric population, increasing demand for minimally invasive procedure, and high per-capita income this market is anticipated to continue its dominance over the forecast period. By 2022, the growth of the European market is expected to slow down due to the saturation of the market. Asia Pacific regions include India, Japan, China, Myanmar, Brazil, and other Asian countries. This region is expected to show lucrative growth owing to increasing disposable income, high population base, and improving healthcare infrastructure.

Forecast Period2022 to 2030
Base Year2021
Historic Years2018
Quantitative UnitsRevenue in USD Billion, Volumes in Units, Pricing in USD
Segments CoveredProduct and Service (Resting ECG, Stress ECG Devices, Holter Monitors, Implantable Loop Recorders, Event Monitors, MCT Devices, Smart ECG Monitors), Lead Type (12-lead ECG Devices, 5-lead ECG Devices, 3-lead ECG Devices, 6-lead ECG Devices, Single-lead, Other Lead Types), End User (Hospitals, Clinics, and Cardiac Centers, Ambulatory Surgical Centers, Other End Users)
Countries CoveredU.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players CoveredGeneral Electric Company (US), Koninklijke Philips N.V. (Netherlands), NIHON KOHDEN CORPORATION. (Japan), Hill-Rom Services, Inc. (US), Ambu A/S. (Denmark), SCHILLER (India), ACSDiagnostics. (US), BPL, FUKUDA DENSHI (Japan), BioTelemetry, Inc. (US), OSI Systems, Inc. (US), BTL. (US), Allengers (India), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), EDAN Instruments, Inc. (China), Cardioline S.P.A. (Italy), SUZUKEN CO., LTD. (Japan), Norav Medical (US), BIONET, VectraCor, Inc., Nexus Lifecare (India), Midmark Corporation (US), Spacelabs Healthcare (US), Innomed Medical Inc. (Hungary).
Market Opportunities
  • The rising prevalence of lifestyle and cardiovascular illnesses
  • The ageing population
  • Technological advancements in wireless monitoring and wearable devices
  • Untapped developing markets

The market is highly competitive due to the presence of a large number of market players. Companies have to invest a large amount of money for research and development to avoid being obsolete for the market. Some of the major drivers of the global diagnostic electrocardiograph market are GE Healthcare, Schiller AG, Spacelabs Healthcare, Philips Healthcare, Cardionet, Mindray Medical, Mortara Instrument Inc., Nihon Kohden Corporation, Welch Allyn and Compumed Inc to name a few. Firms have to go through many business development activities such as mergers, acquisitions, etc. to survive in the long run.

Table of content

Table of Contents

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Covered
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.5 Data Triangulation
2.5.1 Assumptions for the Study
2.5.2 Limitations

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 31)
4.1 Diagnostic Electrocardiograph Market Overview
4.2 Asia Pacific: Diagnostic Electrocardiograph Market Share, By End User & Country (2018)
4.3 Diagnostic Electrocardiograph Market, By Lead Type (2019–2024)
4.4 Geographic Snapshot of the Diagnostic Electrocardiograph Market

5 Market Overview (Page No. – 35)
5.1 Introduction
5.1.1 Drivers Rising Incidence of Lifestyle and Cardiovascular Diseases Increasing Geriatric Population Technological Advancements in Wireless Monitoring and Wearable Devices
5.1.2 Opportunities Untapped Emerging Markets
5.1.3 Challenges Dearth of Skilled Professionals
5.1.4 Trends Mergers, Acquisitions, and Joint Ventures

6 Diagnostic Electrocardiograph Market, By Product & Service (Page No. – 39)
6.1 Introduction
6.2 Products
6.3 Resting ECG Devices
6.3.1 Low Cost, Ease of Use, and Simplicity have Driven the Adoption of Resting ECG Devices
6.4 Stress ECG Devices
6.4.1 The High Cost of These Devices is Negatively Impacting Market Growth
6.5 Implantable Loop Recorders
6.5.1 High Cost and Limited Applications are Hampering Market Growth
6.6 Mobile Cardiac Telemetry Devices
6.6.1 Increasing Demand for Cardiac Monitoring Solutions in Home Care Settings to Propel Market Growth
6.7 Event Monitors
6.7.1 Increasing Outsourcing of Monitoring Devices to Propel Market Growth
6.8 Holter Monitors
6.8.1 Short Duration of Monitoring is A Key Restraint for Market Growth
6.9 Smart ECG Monitors
6.9.1 Lack of Data Security is Hampering the Growth of This Segment
6.10 Software & Services

7 Diagnostic Electrocardiograph Market, By Lead Type (Page No. – 54)
7.1 Introduction
7.2 12-Lead ECG Devices
7.2.1 Use in Pre-Hospital and Clinic Settings has Driven the Adoption of 12-Lead ECG Devices
7.3 5-Lead ECG Devices
7.3.1 Use in Patient Monitoring Will Drive the Growth of the 5-Lead ECG Devices Market
7.4 3-Lead ECG Devices
7.4.1 Market Growth is Driven By Their Capability to Meet the Needs of Multiple Diagnostic Tests Simultaneously
7.5 6-Lead ECG Devices
7.5.1 6-Lead ECG Devices are Mainly Used in Remote Patient Monitoring
7.6 Single-Lead ECG Devices
7.6.1 Ease of Use for Diagnosis and Quick Results have Increased the Use of Single-Lead ECG Devices
7.7 Other Lead Types

8 Diagnostic Electrocardiograph Market, By End User (Page No. – 63)
8.1 Introduction
8.2 Hospitals, Clinics, and Cardiac Centers
8.2.1 in 2018, the Hospitals, Clinics, and Cardiac Centers Segment Accounted for the Largest Share of the Market
8.3 Ambulatory Surgical Centers
8.3.1 Ambulatory Surgical Centers Segment to Grow at the Highest CAGR During the Forecast Period
8.4 Other End Users

9 Diagnostic Electrocardiograph Market, By Region (Page No. – 70)
9.1 Introduction
9.2 North America
9.2.1 US Growing Number of Fda Approvals for Cm and ECG Devices to Support Market Growth in the US
9.2.2 Canada Growing Focus of Government and Private Organizations on Providing Funding for Research Will Drive Market Growth
9.3 Europe
9.3.1 Germany Germany Dominates the Diagnostic ECG Market in Europe
9.3.2 France Rising Prevalence of Heart Failure Will Drive the Adoption of Diagnostic ECG Devices in France
9.3.3 UK Rising Demand for Home-Based Smart ECG Devices Will Support Market Growth
9.3.4 Italy Rising Incidence of Heart Diseases Will Increase the Use of Diagnostic ECG
9.3.5 Spain Rising Geriatric Population Will Support Market Growth in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan High Healthcare Expenditure and Favorable Reimbursement and Insurance Coverage Will Support Market Growth in Japan
9.4.2 China Government Support for Infrastructural Improvement Will Drive Market Growth
9.4.3 India Government Initiatives Will Propel Market Growth in India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 100)
10.1 Introduction
10.2 Market Ranking, 2018
10.3 Competitive Leadership Mapping (2019)
10.3.1 Vendor Inclusion Criteria
10.3.2 Visionary Leaders
10.3.3 Innovators
10.3.4 Dynamic Differentiators
10.3.5 Emerging Companies
10.4 Global Diagnostic Electrocardiograph Market: Competitive Leadership Mapping, 2019
10.5 Competitive Scenario
10.5.1 Collaborations, Agreements, and Partnerships (2016–2019)
10.5.2 Product Launches and Approvals (2016–2019)
10.5.3 Expansions (2016–2019)
10.5.4 Mergers and Acquisitions (2016–2019)

11 Company Profiles (Page No. – 105)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 GE Healthcare
11.2 Koninklijke Philips N.V.
11.3 Nihon Kohden Corporation
11.4 Hill-Rom Holdings, Inc.
11.5 Ambu A/S
11.7 ACS Diagnostics
11.8 BPL Technologies
11.10 Biotelemetry, Inc.
11.11 OSI Systems, Inc.
11.12 BTL
11.13 Allengers Medical Systems, LTD.
11.15 Edan Instruments, Inc.
11.16 Cardioline SpA
11.17 Suzuken Co., LTD.
11.18 Norav Medical
11.19 Bionet Co.,

Major Companies

General Electric Company (US), Koninklijke Philips N.V. (Netherlands), NIHON KOHDEN CORPORATION. (Japan), Hill-Rom Services, Inc. (US), Ambu A/S. (Denmark), SCHILLER (India), ACSDiagnostics. (US), BPL, FUKUDA DENSHI (Japan), BioTelemetry, Inc. (US), OSI Systems, Inc. (US), BTL. (US), Allengers (India), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), EDAN Instruments, Inc. (China), Cardioline S.P.A. (Italy), SUZUKEN CO., LTD. (Japan), Norav Medical (US), BIONET, VectraCor, Inc., Nexus Lifecare (India), Midmark Corporation (US), Spacelabs Healthcare (US), Innomed Medical Inc. (Hungary).


By Product and Service:

  • Product
    • Resting ECG Devices
    • Stress ECG Devices
    • Holter Monitors
    • Implantable Loop Recorders
    • Event Monitors
    • MCT Devices
    • Smart ECG Monitors
  • Software and Service

By Lead Type:

  • 12-lead
  • 5-lead
  • 3-lead
  • 6-lead
  • Single-lead
  • Other Lead Types

By End User

  • Hospitals, Clinics, & Cardiac Centers
  • Ambulatory Surgical Centers
  • Other End Users

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF